969 North Mason, Suite 240

St. Louis, MO 63141

Call The CRC

(314) 514-8509

969 North Mason, Suite 240

St. Louis, MO 63141

Call The CRC

(314) 514-8509

Current Study Opportunities at The CRC

Studies at CRC can change frequently.  For the most up to date information of current enrolling studies please fill out the form on the right or call 314-514-8509 ext 12 to see if you qualify for a study. Studies listed were updated on 1-12-22.

Study #1 : Investigational Asthma study comparing an approved combination inhaler for versus an investigational combination inhaler.

Brief description of study

This study requires 8 visits over approximately 24 weeks. Morning appointments required. Subjects must have asthma  for at least 6 months and currently treating with medium to high dose inhaled steroids for at least 8 weeks. Patients must be 12-80 years of age, non smoker and BMI (Body Mass Index) of less than 40. 

Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.

 

Study #2: Investigational asthma study comparing once daily oral medication as add-on therapy to placebo.

Brief description of study

This study requires 4 visits over approximately 7 weeks. 2 of the visits are overnight in our clinic. Subjects must be on a medium to high daily dose of inhaled steroids or any daily dose of combination inhaled steroids and LABA for at least 3 months. Subjects will stay on their daily inhaled asthma therapy throughout the study. Subjects must be between 18-55 years of age, non-smoker, with a BMI (body mass index) of less than 30.

Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.

 

Study #2A : An asthma research study assessing safety and efficacy of an inhaled once daily medication when added to patients already using maintenance inhalers. All subjects are switched to Advair 250 or 500 during the trial.

Brief description of study

This study has 11-12 visits and may be completed in 7 months. Subjects must be using maintenance inhalers and had an asthma flare requiring oral steroids within the last 12 months.

Visits must be done in the morning and can be scheduled Monday-Saturday. Compensation for participation may be provided for those who qualify.

Please call 314-514-8509 or email generalmailbox@clinicalresearchcenter.com to learn more

Clinical Study Identifier: TX228576

Study #3 : COPD Study enrolling for those using rescue inhaler as needed or using daily maintenance inhalers

Brief description of study

This study is testing the safety and efficacy of a nebulized investigational medication for the treatment of COPD.

This study has either 6 visits over 28 weeks or 10 visits over 52 weeks. Study related pulmonary function testing, chest x ray, lab work, ECG’s and physical exams are included at no cost and compensation for participation may be provided.

Please call 314-514-8509 or email generalmailbox@clinicalresearchcenter.com to learn more details.

Study #4 : Moderate to Severe Asthma Research Study for those currently using medium to high dose controller medication for at least 3 months and have required an oral steroid for a flare in breathing at least once in the last 12 months.

Brief description of study

This investigational research study is enrolling moderate to severe asthmatics.

To qualify you must be on inhaled maintenance medications and have required oral steroids at least once in the last year, for asthma. The study consists of 17 visits over approximately 7-8 months. Subjects will remain on current asthma controllers. The study medication is an injectable investigational medication and will be given every 2 weeks.

Pulmonary function test will be performed and compensation will be provided for those who qualify. Please call 314-514-8509 or email generalmailbox@clinicalresearchcenter.com

Clinical Study Identifier: TX228636

Study #6 : Research Study for Chronic Hives and/or Chronic Urticaria

Brief description of study

This study requires 13 visits over approximately 60 weeks. Visits include study related lab work, ECG’s, and physical exams. This is an investigational twice daily oral medication for the treatment of uncontrolled hives. 

Subjects must have chronic hives diagnosed for at least 6 months and suffer with these hives despite using an oral long acting antihistamine. These hives must be chronic and spontaneous and not have a known cause. Subjects must be over 18 years of age and 

Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.

 

Study #7 : COPD Research Study for Subjects currently on triple therapy and had at least 1 COPD exacerbation

Brief description of study

This study requires 7 visits over approximately 24 weeks. Subjects must have physician diagnosed COPD and currently treating with triple therapy inhaled medication and was hospitalized or experienced 1 or more COPD flares requiring oral steroids or antibiotics. Subjects will be over 40 years of age and have a current or former smoke history and BMI (Body Mass Index) of less than 40.

Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.

 

Study #8 : An investigational research study of an inhaled triple therapy versus placebo for people with moderate to severe asthma.

Brief description of study

This investigational research study has 15 visits.  Subjects must be currently using medium to high dose inhaled maintenance medication and experienced an asthma exacerbation requiring oral steroids within the past year.  This study does have a BMI (Body Mass Index) restriction of less than 40. Must be 12-80 years of age and non smoker with little to no previous smoke history. Compensation for participation may be provided for those who qualify.

Please fill out Volunteer Questionnaire or call 314-514-8509

Clinical Study Identifier: TX228637

Contact CRC
By acknowledging or signing the agreement, the customer is authorizing The Clinical Research Center to periodically send text message updates about current or future studies that may be of interest. The Clinical Research Center will send occasional texts pertaining to studies that may be of interest to you or studies that you are enrolled in. You can opt-out at any time. Text and data rates may apply. Privacy Policy.